Neurociencias
Departamento
Universidad de Sevilla
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Sevilla (11)
2024
-
Proxy measures for the assessment of psychotic and affective symptoms in studies using electronic health records
BJPsych Open, Vol. 10, Núm. 1
2021
-
Clinical investigation and informed consent form in times of COVID-19 pandemic. A vision from the comitee ethics of research
Medicina Clinica
-
Selective deletion of Caspase-3 gene in the dopaminergic system exhibits autistic-like behaviour
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 104
2017
-
Single oral dose of cannabinoid derivate loaded PLGA nanocarriers relieves neuropathic pain for eleven days
Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 13, Núm. 8, pp. 2623-2632
2016
-
Protocolo y metodología del estudio epidemiológico de la salud mental en Andalucía: PISMA-ep
Revista de Psiquiatria y Salud Mental, Vol. 9, Núm. 4, pp. 185-194
2008
-
Development and spatial representation of synthetic indexes of outpatient mental health care in Andalusia (Spain)
Epidemiologia e Psichiatria Sociale, Vol. 17, Núm. 3, pp. 192-200
2007
2001
-
Effectiveness of repeated administration of a new oral naltrexone controlled-release system on morphine analgesia
Journal of Pharmacy and Pharmacology, Vol. 53, Núm. 9, pp. 1201-1205
2000
-
Preclinical study of an oral controlled release naltrexone complex in mice
Journal of Pharmacy and Pharmacology, Vol. 52, Núm. 6, pp. 659-663
1997
-
Implication of β1- and β2-adrenergic receptors in the antinociceptive effect of tricyclic antidepressants
European Neuropsychopharmacology, Vol. 7, Núm. 2, pp. 139-145
1996
-
Preclinical study of a controlled release oral morphine system in rats
International Journal of Pharmaceutics, Vol. 139, Núm. 1-2, pp. 237-241